| 000 | 01603 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516043422.0 | ||
| 264 | 0 | _c20120301 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a2041-4889 | ||
| 024 | 7 |
_a10.1038/cddis.2011.58 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarbone, D | |
| 245 | 0 | 0 |
_aThe Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance. _h[electronic resource] |
| 260 |
_bCell death & disease _cJun 2011 |
||
| 300 |
_ae174 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMesothelioma _xmetabolism |
| 650 | 0 | 4 |
_aNitrophenols _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSpheroids, Cellular _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aRyan, J A | |
| 700 | 1 | _aKolhatkar, N | |
| 700 | 1 | _aChacko, A D | |
| 700 | 1 | _aJablons, D M | |
| 700 | 1 | _aSugarbaker, D J | |
| 700 | 1 | _aBueno, R | |
| 700 | 1 | _aLetai, A G | |
| 700 | 1 | _aCoussens, L M | |
| 700 | 1 | _aFennell, D A | |
| 700 | 1 | _aBroaddus, V C | |
| 773 | 0 |
_tCell death & disease _gvol. 2 _gp. e174 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/cddis.2011.58 _zAvailable from publisher's website |
| 999 |
_c20952006 _d20952006 |
||